OPREGEN Trademark

Trademark Overview

On Wednesday, July 8, 2009, a trademark application was filed for OPREGEN with the United States Patent and Trademark Office. The USPTO has given the OPREGEN trademark a serial number of 77776614. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, October 30, 2021. This trademark is owned by Cell Cure Neurosciences Ltd.. The OPREGEN trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical use, namely, living cells intended for use in the treatment of retinal degenerative disease
opregen

General Information

Serial Number77776614
Word MarkOPREGEN
Filing DateWednesday, July 8, 2009
Status800 - REGISTERED AND RENEWED
Status DateSaturday, October 30, 2021
Registration Number3927366
Registration DateTuesday, March 8, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2010

Trademark Statements

Goods and ServicesCells for medical use, namely, living cells intended for use in the treatment of retinal degenerative disease
Translation of Words in MarkThe wording "OPREGEN" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 13, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCell Cure Neurosciences Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCARLSBAD, CA 92008
Party NameCell Cure Neurosciences Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJerusalem 91121
IL
Party NameCell Cure Neurosciences Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJerusalem 91121
IL

Trademark Events

Event DateEvent Description
Friday, July 22, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 22, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, October 30, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, October 30, 2021REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, October 30, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, October 28, 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, October 15, 2021POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Friday, October 15, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 4, 2021TEAS SECTION 8 & 9 RECEIVED
Monday, November 23, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 23, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 23, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 23, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 23, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, March 8, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, September 9, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, September 9, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, September 8, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 18, 2016TEAS SECTION 8 & 15 RECEIVED
Tuesday, March 8, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 18, 2012REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Tuesday, June 5, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 5, 2012TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 8, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, December 21, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2010PUBLISHED FOR OPPOSITION
Wednesday, November 17, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, November 6, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 5, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 5, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 2, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, September 13, 2010NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, September 13, 2010INQUIRY TO SUSPENSION E-MAILED
Monday, September 13, 2010SUSPENSION INQUIRY WRITTEN
Friday, September 3, 2010SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Wednesday, March 3, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, March 3, 2010LETTER OF SUSPENSION E-MAILED
Wednesday, March 3, 2010SUSPENSION LETTER WRITTEN
Wednesday, March 3, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 3, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 26, 2010ASSIGNED TO LIE
Monday, February 1, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 5, 2010ASSIGNED TO EXAMINER
Tuesday, October 13, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 13, 2009NON-FINAL ACTION E-MAILED
Tuesday, October 13, 2009NON-FINAL ACTION WRITTEN
Tuesday, October 6, 2009ASSIGNED TO EXAMINER
Monday, July 13, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 11, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

opregen cells retinal degenerative disease treatment intended medical namely living